熱門資訊> 正文
立体声合成在欧盟的MDR监管框架下获得CE标志重新认证
2024-05-24 20:58
- Stereotaxis (NYSE:STXS) on Friday announced that it has received CE Mark recertification under the European Union’s new Medical Device Regulation regulatory framework.
- The recertification under MDR covers all Stereotaxis devices currently available in Europe.
- Source: Press Release
More on Stereotaxis
- Stereotaxis Makes A Strategic Acquisition Bolstering Its Future
- Major Regulatory Approvals Coming For Stereotaxis In The Next 10 Months
- Stereotaxis Q1 2024 Earnings Preview
- Seeking Alpha’s Quant Rating on Stereotaxis
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
